Showing results (1051-1060 of 6,303) with videos related to

Sort By:
Pageof 631
Addiction (Abingdon, England)|October 21, 2014
Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disordersClaudia Sannibale, Maree Teesson, Mark Creamer, et al.
Addiction (Abingdon, England)|August 8, 2014
Genetic influences on alcohol-related hangoverWendy S Slutske, Thomas M Piasecki, Lisa Nathanson, et al.
Addiction (Abingdon, England)|July 31, 2014
Neuroimaging craving: urge intensity mattersStephen J Wilson, Michael A Sayette
Addiction (Abingdon, England)|July 30, 2013
Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population studyMarlous Tuithof, Margreet Ten Have, Wim van den Brink, et al.
Addiction (Abingdon, England)|July 22, 2014
The burden of premature opioid-related mortalityTara Gomes, Muhammad M Mamdani, Irfan A Dhalla, et al.
Addiction (Abingdon, England)|August 22, 2013
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trialYih-Ing Hser, Andrew J Saxon, David Huang, et al.
Addiction (Abingdon, England)|August 22, 2013
Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trialKathryn E McCollister, Michael T French, Derek M Freitas, et al.
Addiction (Abingdon, England)|August 22, 2013
Causes of death in a cohort treated for opioid dependence between 1985 and 2005Louisa Degenhardt, Sarah Larney, Deborah Randall, et al.
Addiction (Abingdon, England)|August 22, 2013
'No-one actually goes to a shop and buys them do they?': attitudes and behaviours regarding illicit tobacco in a multiply disadvantaged community in EnglandMartine Stead, Laura Jones, Graeme Docherty, et al.
Addiction (Abingdon, England)|August 15, 2013
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropionSean P David, David R Strong, Adam M Leventhal, et al.
Pageof 631